Stockscreener 앱 받기
24.60
93.55%
11.89
시간 외 거래:
20.86
-3.74
-15.20%
전일 마감가:
$12.71
열려 있는:
$21.29
하루 거래량:
4.31M
Relative Volume:
48.65
시가총액:
$173.92M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+371.26%
1개월 성능:
+241.67%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$15.30
$24.88
1주일 범위
$4.55
$24.88
52주 변동 폭
$4.40
$24.88
Liminatus Pharma Inc Stock (LIMN) Company Profile
명칭
Liminatus Pharma Inc
전화
213-273-5453
주소
6 CENTERPOINTE DR., LA PALMA
LIMN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
24.60 | 657.18M | 0 | 0 | 0 | 0.00 |
|
LION
Lionsgate Studios Corp
|
6.70 | 1.93B | 2.82B | -191.60M | -407.10M | -0.6794 |
|
AACT
Ares Acquisition Corporation Ii
|
11.42 | 699.01M | 0 | 16.92M | -1.35M | 0.29 |
|
CEP
Cantor Equity Partners Inc
|
40.22 | 514.82M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.51 | 464.45M | 0 | 0 | 0 | 0.00 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.77 | 463.59M | 0 | 1.30M | 0 | 0.0301 |
Liminatus Pharma Inc 주식(LIMN)의 최신 뉴스
Greif Posts Upbeat Earnings, Joins Planet Labs PBC, IperionX, Owens & Minor And Other Big Stocks Moving Higher On Thursday - Benzinga
Crude Oil Moves Higher; Ciena Posts Downbeat Earnings - Benzinga
Liminatus Pharma stock gains on regaining compliance with Nasdaq - Seeking Alpha
Dow Dips Over 100 Points; US Jobless Claims Increase - Benzinga
Liminatus Pharma shares soar on Nasdaq compliance news By Investing.com - Investing.com Canada
Liminatus Pharma shares soar on Nasdaq compliance news - Investing.com India
Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Liminatus Pharma Gains Compliance With Nasdaq Filing Requirements; Shares up Pre-Bell - marketscreener.com
Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - Asianet Newsable
Liminatus Pharma regains Nasdaq listing compliance - TipRanks
Liminatus Pharma Regains Nasdaq Compliance After Filing Delay - TipRanks
Liminatus Pharma, Inc.Class A Common Stock (Nasdaq:LIMN) Stock Quote - FinancialContent
Liminatus Pharma Delays Quarterly Report Filing - TipRanks
Liminatus Pharma’s Merger with Iris Acquisition Corp. - Global Legal Chronicle
Iris Acquisition, Liminatus Pharma Sign SPAC Merger Deal - marketscreener.com
LIMN Stock Price and Chart — NASDAQ:LIMN - TradingView
Iris Acquisition Corp confirms delisting and shareholder vote outcomes - Investing.com
Iris Acquisition Corp announces preliminary proxy statement - Investing.com
Iris Acquisition Corp announces business combination - Investing.com
Iris Acquisition Corp announces business combination with Liminatus Pharma - Investing.com
New company Liminatus Pharma Inc to develop three cancer treatments - Labiotech.eu
A fledgling biotech goes SPAC route to bankroll cancer vaccine, CAR-T and CD47 - Endpoints News
Liminatus Pharma and Iris Acquisition to Combine in $334M Deal - The SPAC Conference
Liminatus Pharma and Iris Acquisition Corp to Combine - citybiz
Holland & Knight Partner Seth Belzley Ranked Among Denver’s Outstanding "40 Under 40" Business Professionals - Holland & Knight
Liminatus Pharma Inc (LIMN) 재무 분석
Liminatus Pharma Inc (LIMN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.00%
0.10%
자본화:
|
볼륨(24시간):